By Application - Type 2 diabetes mellitus segment was valued at USD 23.54 billion in 2023 By Route of Administration - Subcutaneous injection segment accounted for the largest market revenue share in 2023 Market Size & Forecast Market Opportunities: USD 123.03 billion Market Future Opportunities: USD 100.08 billion CAGR from 2024 to 2029 : 25.3% Market Summary The GLP 1 analogues market is undergoing a significant transformation, driven by its expanding role in addressing interconnected metabolic diseases
Easier to source, cheaper than Wegovy, and Canadian clinicians prescribe it off-label routinely
5-in-1 Gut Health Supplement for Men & Women: Features a supergut GLP-1 prebiotic mix, dietary fiber supplement, Probiotics, Postbiotics, Digestive Enzymes & L-Glutamine for smooth digestion
This dual-action system often aids in greater weight loss to help patients reach their goals more quickly
Distinctive modulation of inflammatory and metabolic parameters in relation to zinc nutritional status in adult overweight/obese subjects
Malaki M, Xu W, Kasar AK et al (2019) Advanced metal matrix nanocomposites
